Axishil 5mg Tablet
By Axishil
Rx
14 Tablet in a Bottle

Composition
Axitinib(5mg)

Manufacturer - Shilpa Medicare Ltd
12-6-214/A1, Hyderabad Road, Raichur – 584 135, Karnataka, India.

Expires on or after
January, 2027

liver
Axishil 5mg Tablet needs to be used carefully in patients with liver disease. It may require a change in dosage, so consulting your doctor is crucial. Information about using Axishil 5mg Tablet in severe liver disease patients is limited. If you have a history of liver issues, make sure to inform your doctor before starting this medication. Axishil 5mg Tablet can raise liver enzymes to dangerous levels, which may have severe consequences. Therefore, individuals with moderate liver problems should take this medicine with caution. Your doctor might recommend liver function tests to be carried out regularly during the treatment with this medication.

kidney
Axishil 5mg Tablet is safe for patients with kidney disease. Inform your doctor about any kidney issues before using this medicine, as dose adjustment may be needed based on your condition.

alcohol
Consult your doctor when consuming alcohol with Axishil 5mg Tablet. Limit alcohol intake while taking this medication.

driving
When taking Axishil 5mg Tablet, it may reduce alertness and cause dizziness or drowsiness. Avoid driving if experiencing these effects. Refrain from driving or operating machinery until sure you can do so safely while on this medication.

pregnancy
Axishil 5mg Tablet is not safe during pregnancy due to risks to the developing baby. Your doctor may only prescribe it in life-threatening situations after assessing benefits versus risks. It can cause harm to the embryo and fetus. Inform your doctor if pregnant or planning pregnancy, use effective birth control during treatment.

breastfeeding
Axishil 5mg Tablet may not be safe during breastfeeding as it may pass into breastmilk and potentially harm the baby. Inform your doctor before using this medication while breastfeeding, as they can assess the risks and benefits for you and your child.
Habit Forming | No |
Chemical Class | Enzamide and Indazole Derivative |
Therapeutic Class | - |
Action Class | Tyrosine kinase inhibitors |
₹3735
Inclusive of all taxes
Content verified by

Dr. Gowri Kulkarni
MBBS - General Medicine, DNB - Psychiatry, MRCGP [INT] Family Medicine, BSIC (BACP)
Last update on 18-Nov-2024